New AI tool analyses DNA for faster, affordable cancer monitoring

New Delhi: A team of researchers from Singapore has developed a new artificial intelligence (AI)-based method that makes tracking cancer easier and faster-using blood tests.

The method called “Fragle”, developed by a team from the A*STAR Genome Institute of Singapore (A*STAR GIS), requires only a small blood sample, and analyses the size of DNA fragments in the blood to reveal distinct patterns that differentiate cancer DNA from healthy DNA. This can help doctors track cancer treatment responses more accurately and frequently.

“Just as scientists tracked Covid-19 outbreaks by detecting viral particles in wastewater, Fragle analyses DNA fragments in blood to monitor cancer treatment response and detect relapse early,” said lead author Dr. Anders Skanderup, Senior Principal Scientist at A*STAR GIS Laboratory of Computational Cancer Genomics.

Existing methods for measuring cancer DNA in the blood, also known as circulating tumour DNA (ctDNA), often require complex and expensive DNA sequencing to screen for common cancer mutations. However, because cancer mutations vary between patients, test results can be inconsistent, making it difficult for doctors to track cancer treatment response with blood tests effectively.

On the other hand, Fragle uses AI to analyse the size of DNA fragments in the blood.

Cancer DNA tends to exhibit different size patterns compared to healthy DNA, and the Fragle AI-model can identify these differences using very small amounts of DNA. As a result, the method allows for faster and more affordable cancer tracking, said the researchers in the paper, published in the journal Nature Biomedical Engineering.

It has also demonstrated high reliability, delivering accurate results across blood samples from hundreds of cancer patients and distinct cancer types. In addition, the method is versatile and compatible with most DNA profiling techniques commonly used in hospitals or offered by commercial providers.

In an ongoing study of more than 100 clinical trial patients, the GIS-NCCS team is using Fragle to monitor ctDNA levels every two months during treatment, with the aim of catching signs of relapse before they appear on routine scans.

The team is also studying whether early changes in ctDNA can identify which patients are likely to have a favourable or poor response to the therapy. The goal of the study is to assess the value of incorporating ctDNA tests in routine monitoring of cancer patients during treatment.

IANS

 

Samsung set to launch tri-foldable phone later this year: Roh Tae-moon

Seoul: Samsung Electronics plans to debut its first tri-folding smartphone later this year, adding a new form factor to its flagship Galaxy lineup. "We are working hard to release it...

AI decodes gut bacteria to provide clues about health

Tokyo: For the first time, researchers from the University of Tokyo have used a special kind of artificial intelligence (AI) called a Bayesian neural network to probe a dataset on...

New gene therapy shows potential for restoring hearing loss

New Delhi: In a significant scientific breakthrough, an international team of researchers has developed a novel gene therapy that can improve hearing in children and adults with congenital deafness or...

Lightning strikes: New App to provide early warning to be developed, says Maha Minister

Mumbai: Minister of Disaster Management, Girish Mahajan on Wednesday said in the Maharashtra Assembly that the government is taking the help of modern technology to prevent deaths due to lightning...

India’s digital identity adoption surges amid rising trust, AI integration: Report

New Delhi: As India’s digital ecosystem expands at an unprecedented pace, Indian consumers are rapidly embracing new-age identity technologies while balancing convenience with security concerns, a new report said on...

Broadband subscribers in India up 3.37 pc at 974.87 million in May

New Delhi: The total number of broadband subscribers increased from 943.09 million at the end of April to 974.87 million at May-end with a monthly growth rate of 3.37 per...

India tops global GenAI adoption with 92 pc workforce usage: Report

New Delhi: India is leading the global charge in the adoption of generative AI tools at the workplace, with 92 per cent of employees regularly using such technology -- far...

India’s first Quantum Valley to be launched in Andhra Pradesh by January 2026

Vijayawada: Andhra Pradesh will launch India’s first full-stack Quantum Valley in Amaravati by January 2026, integrating hardware, software, talent, and research capabilities, officials said on Wednesday. It is a pioneering...

ICMR’s affordable test kits boost diagnosis of genetic blood disorders in India

New Delhi: Simple and affordable point-of-care (POC) test kits, developed by scientists at the Indian Council of Medical Research (ICMR), are enhancing the diagnosis of genetic blood disorders like Haemophilia...

Indian scientists produce green hydrogen by splitting water molecules

New Delhi: A team of Indian scientists from the Centre for Nano and Soft Matter Sciences (CeNS), Bengaluru, an autonomous institute of the Department of Science and Technology (DST), have...

India at forefront of the global digital economy in 11 years: Arundhati Bhattacharya

New Delhi: Arundhati Bhattacharya, President and CEO at Salesforce-South Asia, on Tuesday said that the digital ecosystem in India has grown rapidly in the last 11 years under the Prime...

LG Display files patent suit in US against China’s Tianma Microelectronics

Seoul: LG Display, a global leader in display panel manufacturing, has filed a patent infringement lawsuit in the United States against Chinese firm Tianma Microelectronics to protect its intellectual property,...

Read Previous

‘At 21, I haven’t seen more talented player’: Venkatesh lauds Akshat Raghuwanshi for match-defining knock in MPL

Read Next

Five youth drowned in Godavari river in Telangana

WP2Social Auto Publish Powered By : XYZScripts.com